![]() Unfortunately, the drug’s nonproprietary name, idaru CIZUmab, shares its first five letters with the antineoplastic drug IDArubicin. Hospital pharmacies may stock Praxbind if dabigatran patients are treated in the hospital or seen in the emergency department. ![]() Last month the US Food and Drug Administration (FDA) granted accelerated approval to PRAXBIND (idarucizumab) for use in patients who take PRADAXA (dabigatran) and suffer a life-threatening bleeding event.
0 Comments
Leave a Reply. |